Skip to main content

Retail Clinics

  • Baxter on verge of revolutionizing flu shot life cycle

    DEERFIELD, Ill. — Baxter International on Tuesday announced results of a study published in this week's issue of The Lancet that demonstrated effectiveness and tolerability of the company’s Preflucel in protecting against seasonal influenza.

  • N.Y. Medicaid program redesign could save state millions

    WASHINGTON — The New York State Health Department has proposed a plan that could save the state’s Medicaid program $350 million through 2015.

    The proposal would redesign the program so that it acts more like Medicare and private insurers. According to the Pharmaceutical Care Management Association, a trade group for pharmacy benefit managers, the program currently uses fewer generic drugs and pays pharmacists twice what they get from private insurers and Medicare.

  • HHS unveils National Vaccine Plan

    WASHINGTON — The Department of Health and Human Services on Wednesday unveiled a new National Vaccine Plan to enhance coordination of all aspects of federal vaccine and immunization activities with the goal to ensure that all Americans can gain access to vaccines.

    “Vaccines are a critical cornerstone of the public health system,” stated Howard Koh, assistant secretary for health for HHS. “The National Vaccine Plan articulates a vision that will ensure that the nation’s prevention strategies protect the public for the next decade and beyond.”

  • Mylan gets approval for generic version of Vfend

    PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday.

    Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the 50-mg and 200-mg strengths. The drug is a triazole antifungal agent.

    The tablets are a generic version of Pfizer’s Vfend, which had sales of $186 million in 2010, according to IMS Health. Mylan launched its version of the drug under a settlement with Pfizer.

  • Report: Walmart opens second retail clinic with St. Mary's Medical Group

    RENO, Nevada — St. Mary's Medical Group once again is teaming up with Walmart to open up a second retail-based health clinic in Nevada, according to local news reports.

    According to reports, the second location is opening on Tuesday at the Walmart store on Kietzke Lane.

  • Study: Energy drink use by young people could lead to health problems

    MIAMI — New research published in the Feb. 14 online edition of Pediatrics found that prolonged use of energy drinks by young people can lead to potentially adverse health outcomes.

    Researchers at the University of Miami's Leonard M. Miller School of Medicine noted that in the United States, energy drinks were consumed by 30% to 50% of adolescents and young adults, according to self-report surveys. Additionally, adolescent caffeine intake averaged 60 mg/day to 70 mg/day and ranged up to 800 mg/day, the researchers said.

  • AccuDial developing child-proof children’s dosing syringe

    PALM BEACH GARDENS, Fla. — AccuDial Pharmaceutical earlier this month announced it has developed a new patent-pending line of child-proof container enclosure systems, designed to reduce the accidental or unsupervised ingestion of liquid over-the-counter and prescription medications.

  • FSA restrictions first piece of ObamaCare to be challenged

    WASHINGTON — Recent restrictions imposed on flexible spending accounts appear to be the first piece of ObamaCare to be challenged by the new Congress.

    Sen. Kay Bailey Hutchison, R-Texas, and Rep. Erik Paulsen, R-Minn., on Thursday respectively introduced The Patients’ Freedom to Choose Act, a bill that would repeal two provisions in the Obama healthcare law that limit a patient’s choice in how to use consumer-directed health savings plans, to the Senate and House of Representatives.

X
This ad will auto-close in 10 seconds